Frontiers in Medicine | Regulatory Science

Correction

Published on 05 Jan 2024

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

in Regulatory Science

Hassan Alwafi
Ian C. K. Wong
Abdallah Y. Naser
Amitava Banerjee
Pajaree Mongkhon
Cate Whittlesea
Alaa Alsharif
Li Wei

Frontiers in Medicine

doi 10.3389/fmed.2023.1337712

1,427 views

Original Research

Published on 03 Jan 2024

Transforming medical equipment management in digital public health: a decision-making model for medical equipment replacement

in Regulatory Science

Luying Huang
Wenqian Lv
Qingming Huang
Haikang Zhang
Siyuan Jin
Tong Chen
Bing Shen

Frontiers in Medicine

doi 10.3389/fmed.2023.1239795

5,532 views
5 citations

Brief Research Report

Published on 06 Dec 2023

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

in Regulatory Science

María Lorena Bacigalupo
María Florencia Pignataro
Carolinne Thays Scopel
Sergiy Kondratyuk
Othoman Mellouk
Gabriela Costa Chaves

Frontiers in Medicine

doi 10.3389/fmed.2023.1287542

7,259 views
5 citations

Original Research

Published on 30 Nov 2023

Quality and quantity of data used by Health Canada in approving new drugs

in Regulatory Science

Joel Lexchin

Frontiers in Medicine

doi 10.3389/fmed.2023.1299239

3,764 views
11 citations

Review

Published on 27 Nov 2023

Defining medical liability when artificial intelligence is applied on diagnostic algorithms: a systematic review

in Regulatory Science

Clara Cestonaro
Arianna Delicati
Beatrice Marcante
Luciana Caenazzo
Pamela Tozzo

Frontiers in Medicine

doi 10.3389/fmed.2023.1305756

34,785 views
137 citations

Original Research

Published on 16 Nov 2023

Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study

in Regulatory Science

María Lucila Gonzalez Donna
María Luisa Cabañas León
Cinthia Gauna Colas
Alicia Pomata Gunsett
Silvia Ferreira Maniero
David Olivares Osuna
Ezequiel Klimovsky
Lucas Coradini
Diego Enrico
Matías Chacón

Frontiers in Medicine

doi 10.3389/fmed.2023.1266246

3,846 views
2 citations

Opinion

Published on 09 Nov 2023

What about Health Education? Hegemony, paradigms in tension and alternatives

in Regulatory Science

Matías Blaustein
Fernando Miguel Garelli

Frontiers in Medicine

doi 10.3389/fmed.2023.1289865

2,367 views
1 citation

Original Research

Published on 08 Nov 2023

Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

in Regulatory Science

Prisha Patel
Judith C. Macdonald
Jayanthi Boobalan
Matthew Marsden
Ruben Rizzi
Marianne Zenon
Jinma Ren
Haitao Chu
Joseph C. Cappelleri
Satrajit Roychoudhury

Frontiers in Medicine

doi 10.3389/fmed.2023.1275817

11,650 views
10 citations

Hypothesis and Theory

Published on 30 Oct 2023

A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply

in Regulatory Science

Gergely Németh
Mánuel László Mágó
Zoltán Kaló
Judit Lám
Tamás Balogh
Valentin Brodszky

Frontiers in Medicine

doi 10.3389/fmed.2023.1282698

5,265 views
6 citations

Policy and Practice Reviews

Published on 30 Oct 2023

Real-world evidence for regulatory decision-making: updated guidance from around the world

in Regulatory Science

Leah Burns
Nadege Le Roux
Robert Kalesnik-Orszulak
Jennifer Christian
Jennifer Dudinak
Frank Rockhold
Sean Khozin
John O’Donnell

Frontiers in Medicine

doi 10.3389/fmed.2023.1236462

19,464 views
29 citations

Perspective

Published on 27 Oct 2023

The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?

in Regulatory Science

Jörg Mahlich
Sybille Riou
Matthieu Verry

Frontiers in Medicine

doi 10.3389/fmed.2023.1264021

3,237 views

Policy and Practice Reviews

Published on 27 Oct 2023

A study on the normative path of ethics review in China: based on the perspective of Panopticism

in Regulatory Science

Leqian Wu
Xiangjin Kong

Frontiers in Medicine

doi 10.3389/fmed.2023.1268046

2,832 views
4 citations

Original Research

Published on 23 Oct 2023

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

in Regulatory Science

Lorraine Danks
Boitumelo Semete-Makokotlela
Kennedy Otwombe
Yashmika Parag
Stuart Walker
Sam Salek

Frontiers in Medicine

doi 10.3389/fmed.2023.1265058

5,333 views
7 citations

Original Research

Published on 12 Oct 2023

Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories

in Regulatory Science

Ruitai Fan
Yufei Zheng
Runze Zhou
Narasimha M. Beeraka
Olga A. Sukocheva
Ruiwen Zhao
Shijie Li
Xiang Zhao
Chunying Liu
Song He

Frontiers in Medicine

doi 10.3389/fmed.2023.1203346

6,417 views
6 citations

Original Research

Published on 12 Oct 2023

Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey

in Regulatory Science

Jean-Marc Hoffmann
Anette Blümle
Regina Grossmann
Henry Yau
Britta Lang
Cedric Bradbury

Frontiers in Medicine

doi 10.3389/fmed.2023.1252352

4,525 views
5 citations

Original Research

Published on 11 Oct 2023

Analysis of patients’ privacy and associated factors in the perioperative period

in Regulatory Science

Mingyang Tan
Hongyu Li
Xiaofei Wang

Frontiers in Medicine

doi 10.3389/fmed.2023.1242149

5,921 views
3 citations

Original Research

Published on 10 Oct 2023

Completeness of intervention description in invasive cardiology trials: an observational study of ClinicalTrials.gov registry and corresponding publications

in Regulatory Science

Viktoria Lišnić
Hishaam Ashraf
Marin Viđak
Ana Marušić

Frontiers in Medicine

doi 10.3389/fmed.2023.1276847

2,329 views
1 citation

Perspective

Published on 09 Oct 2023

Taking AIM at serious illness: implementing an access to investigational medicines expanded access program

in Regulatory Science

Meghan Morrison Joly
Terri L. Edwards
Rebecca N. Jerome
Alex Mainor
Gordon R. Bernard
Jill M. Pulley

Frontiers in Medicine

doi 10.3389/fmed.2023.1287449

2,830 views
1 citation

Opinion

Published on 02 Oct 2023

The nexus of social alliances and diverse moral domains: a bedrock for participatory clinical research

in Regulatory Science

Johanna M. C. Blom
Veronica Rivi
Fabio Tascedda
Luca Pani

Frontiers in Medicine

doi 10.3389/fmed.2023.1250247

1,742 views
4 citations

Policy and Practice Reviews

Published on 22 Sep 2023

Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest

in Regulatory Science

Barbara K. Redman

Frontiers in Medicine

doi 10.3389/fmed.2023.1247258

12,361 views
15 citations

Original Research

Published on 21 Sep 2023

Evaluation of medication errors in nursing during the COVID-19 pandemic and their relationship with shift work at teaching hospitals: a cross-sectional study in Iran

in Regulatory Science

Abdolreza Gilavand
Negar Jafarian
Kourosh Zarea

Frontiers in Medicine

doi 10.3389/fmed.2023.1200686

9,294 views
7 citations

Review

Published on 19 Sep 2023

Bibliometric analysis of the current status and trends on medical hyperspectral imaging

in Regulatory Science

Sijia Jiang
Ding Ma
Xin Tan
Mingyu Yang
Qingbin Jiao
Liang Xu

Frontiers in Medicine

doi 10.3389/fmed.2023.1235955

5,266 views
15 citations

Policy and Practice Reviews

Published on 04 Sep 2023

What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements

in Regulatory Science

Nevena Miletic
Sarah Adam
Jacqueline Acquah
Zainab Aziz
Angelika Joos
John M. Mwangi

Frontiers in Medicine

doi 10.3389/fmed.2023.1207954

5,399 views
4 citations

Editorial

Published on 25 Aug 2023

Editorial: Managing healthcare transformation towards P5 medicine

in Regulatory Science

Bernd Blobel
Dipak Kalra

Frontiers in Medicine

doi 10.3389/fmed.2023.1244100

2,667 views
7 citations

518 articles

articles

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

Transforming medical equipment management in digital public health: a decision-making model for medical equipment replacement

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

Quality and quantity of data used by Health Canada in approving new drugs

Defining medical liability when artificial intelligence is applied on diagnostic algorithms: a systematic review

Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study

What about Health Education? Hegemony, paradigms in tension and alternatives

Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply

Real-world evidence for regulatory decision-making: updated guidance from around the world

The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?

A study on the normative path of ethics review in China: based on the perspective of Panopticism

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories

Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey

Analysis of patients’ privacy and associated factors in the perioperative period

Completeness of intervention description in invasive cardiology trials: an observational study of ClinicalTrials.gov registry and corresponding publications

Taking AIM at serious illness: implementing an access to investigational medicines expanded access program

The nexus of social alliances and diverse moral domains: a bedrock for participatory clinical research

Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest

Evaluation of medication errors in nursing during the COVID-19 pandemic and their relationship with shift work at teaching hospitals: a cross-sectional study in Iran

Bibliometric analysis of the current status and trends on medical hyperspectral imaging

What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements

Editorial: Managing healthcare transformation towards P5 medicine